BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33002305)

  • 1. Pulmonary metastasectomy in colorectal cancer: health utility scores by EQ-5D-3L in a randomized controlled trial show no benefit from lung metastasectomy.
    Brew-Graves C; Farewell V; Monson K; Milošević M; Williams NR; Morris E; Macbeth F; Treasure T; Fallowfield L
    Colorectal Dis; 2021 Jan; 23(1):200-205. PubMed ID: 33002305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.
    Milosevic M; Edwards J; Tsang D; Dunning J; Shackcloth M; Batchelor T; Coonar A; Hasan J; Davidson B; Marchbank A; Grumett S; Williams NR; Macbeth F; Farewell V; Treasure T
    Colorectal Dis; 2020 Oct; 22(10):1314-1324. PubMed ID: 32388895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
    Marriott ER; van Hazel G; Gibbs P; Hatswell AJ
    J Med Econ; 2017 Feb; 20(2):193-199. PubMed ID: 27676291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial.
    Treasure T; Farewell V; Macbeth F; Monson K; Williams NR; Brew-Graves C; Lees B; Grigg O; Fallowfield L;
    Trials; 2019 Dec; 20(1):718. PubMed ID: 31831062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
    Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
    Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of EuroQol-5D-3L and Short Form-6D Utility Scores in Family Caregivers of Colorectal Cancer Patients: A Cross-Sectional Survey in China.
    Sun CY; Liu Y; Zhou LR; Wang MS; Zhao XM; Huang WD; Liu GX; Zhang X
    Front Public Health; 2021; 9():742332. PubMed ID: 34660519
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
    Franken MD; de Hond A; Degeling K; Punt CJA; Koopman M; Uyl-de Groot CA; Versteegh MM; van Oijen MGH
    Health Qual Life Outcomes; 2020 Jul; 18(1):240. PubMed ID: 32690011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To what extent does the EQ-5D-3L correlate with the FACT-H&N of patients with oral cancer during the perioperative period?
    Aoki T; Ota Y; Sasaki M; Aoyama KI; Akiba T; Shirasugi Y; Naito M; Shiroiwa T
    Int J Clin Oncol; 2019 Apr; 24(4):350-358. PubMed ID: 30392116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
    Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
    Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
    Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
    Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland.
    Golicki D; Niewada M
    Pol Arch Med Wewn; 2015; 125(1-2):18-26. PubMed ID: 25578383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting.
    Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Senanayake S; Senanayake C; De Silva LSD; Kularatna S
    Ceylon Med J; 2019 Jun; 64(2):52-58. PubMed ID: 31455067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
    Shaw JW; Bennett B; Trigg A; DeRosa M; Taylor F; Kiff C; Ntais D; Noon K; King MT; Cocks K
    Value Health; 2021 Nov; 24(11):1651-1659. PubMed ID: 34711366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
    Bae E; Choi SE; Lee H; Shin G; Kang D
    BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing and transforming PROMIS utility values to the EQ-5D.
    Hartman JD; Craig BM
    Qual Life Res; 2018 Mar; 27(3):725-733. PubMed ID: 29264776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding the evidence for pulmonary metastasectomy in colorectal cancer: the PulMicc trial.
    Migliore M; Milošević M; Lees B; Treasure T; Di Maria G
    Future Oncol; 2015; 11(2 Suppl):15-8. PubMed ID: 25662322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
    Gray LA; Wailoo AJ; Hernandez Alava M
    Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial: a systematic review of published responses.
    Williams NR; Patrick H; Fiorentino F; Allen A; Sharma M; Milošević M; Macbeth F; Treasure T
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35415756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
    Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
    Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.